Diana Eccles

52.3k total citations · 4 hit papers
183 papers, 9.0k citations indexed

About

Diana Eccles is a scholar working on Genetics, Oncology and Molecular Biology. According to data from OpenAlex, Diana Eccles has authored 183 papers receiving a total of 9.0k indexed citations (citations by other indexed papers that have themselves been cited), including 111 papers in Genetics, 60 papers in Oncology and 56 papers in Molecular Biology. Recurrent topics in Diana Eccles's work include BRCA gene mutations in cancer (97 papers), Genetic factors in colorectal cancer (44 papers) and Cancer Genomics and Diagnostics (31 papers). Diana Eccles is often cited by papers focused on BRCA gene mutations in cancer (97 papers), Genetic factors in colorectal cancer (44 papers) and Cancer Genomics and Diagnostics (31 papers). Diana Eccles collaborates with scholars based in United Kingdom, United States and Australia. Diana Eccles's co-authors include D. Gareth Evans, Douglas F. Easton, Nazneen Rahman, Michael R. Stratton, Sheila Seal, Rita Barfoot, Anthony Renwick, Hiran Jayatilake, Lesley McGuffog and Ian Campbell and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Diana Eccles

178 papers receiving 8.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene

2006 689 citations D. Gareth Evans, Diana Eccles et al. profile →
Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results

2008 582 citations Diana Eccles, William D. Foulkes et al. profile →
Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles

2006 513 citations D. Gareth Evans, Diana Eccles et al. profile →
ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles

2006 511 citations D. Gareth Evans, Diana Eccles et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Diana Eccles	4.6k	3.6k	2.9k	2.6k	2.2k	183	9.0k
Melissa C. Southey	4.2k 0.9×	3.9k 1.1×	2.8k 1.0×	2.5k 1.0×	2.0k 0.9×	318	10.0k
Georgia Chenevix‐Trench	3.3k 0.7×	5.2k 1.4×	2.2k 0.8×	1.8k 0.7×	1.7k 0.8×	219	8.7k
Marc Tischkowitz	3.3k 0.7×	3.8k 1.1×	2.5k 0.9×	1.9k 0.7×	1.2k 0.5×	157	7.3k
Jeffrey N. Weitzel	5.1k 1.1×	4.1k 1.1×	4.7k 1.7×	3.0k 1.1×	1.6k 0.7×	222	10.3k
Nicoline Hoogerbrugge	2.8k 0.6×	2.2k 0.6×	2.7k 0.9×	2.1k 0.8×	2.9k 1.3×	247	7.9k
Amanda B. Spurdle	3.1k 0.7×	3.0k 0.8×	1.7k 0.6×	1.8k 0.7×	1.5k 0.7×	242	6.9k
Dominique Stoppa‐Lyonnet	3.1k 0.7×	3.9k 1.1×	2.3k 0.8×	1.9k 0.7×	1.1k 0.5×	239	7.4k
Andrea Eisen	4.9k 1.1×	1.6k 0.4×	3.1k 1.1×	2.9k 1.1×	1.5k 0.7×	189	8.3k
Barbara L. Weber	5.3k 1.2×	5.2k 1.5×	2.8k 1.0×	2.2k 0.8×	1.6k 0.7×	62	9.6k
Gail E. Tomlinson	2.6k 0.6×	4.8k 1.3×	2.0k 0.7×	1.7k 0.6×	1.1k 0.5×	173	8.7k

Countries citing papers authored by Diana Eccles

Since Specialization

Citations

This map shows the geographic impact of Diana Eccles's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diana Eccles with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diana Eccles more than expected).

Fields of papers citing papers by Diana Eccles

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diana Eccles. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diana Eccles. The network helps show where Diana Eccles may publish in the future.

Co-authorship network of co-authors of Diana Eccles

This figure shows the co-authorship network connecting the top 25 collaborators of Diana Eccles. A scholar is included among the top collaborators of Diana Eccles based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diana Eccles. Diana Eccles is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Klein, Kathrin, Oliver Burk, Roman Tremmel, et al.. (2025). Transcription factors of the Nuclear Factor I (NFI) family control hepatocyte differentiation and cytochrome P450 activity in human liver. Pharmacological Research. 221. 107998–107998.

Knott, Craig, Catherine Huntley, Yvonne Walburga Joko-Fru, et al.. (2025). Long-term outcomes of bilateral salpingo-oophorectomy in women with personal history of breast cancer. PubMed. 4(1). e000574–e000574. 1 indexed citations

Kohut, Kelly, Katherine Morton, Lesley Turner, et al.. (2023). Patient decision support resources inform decisions about cancer susceptibility genetic testing and risk management: a systematic review of patient impact and experience. Frontiers in Health Services. 3. 1092816–1092816. 5 indexed citations

Sofianopoulou, Eleni, Diana Eccles, Clare Turnbull, et al.. (2022). Risk of developing a second primary cancer in male breast cancer survivors: a systematic review and meta-analysis. British Journal of Cancer. 127(9). 1660–1669. 9 indexed citations

Schroth, Werner, Thomas E. Mürdter, Robin Michelet, et al.. (2020). Obesity Alters Endoxifen Plasma Levels in Young Breast Cancer Patients: A Pharmacometric Simulation Approach. Clinical Pharmacology & Therapeutics. 108(3). 661–670. 21 indexed citations

Garrett, Alice, Miranda Durkie, Alison Callaway, et al.. (2020). Combining evidence for and against pathogenicity for variants in cancer susceptibility genes: CanVIG-UK consensus recommendations. Journal of Medical Genetics. 58(5). 297–304. 36 indexed citations

Monteiro, Álvaro N.A., Peter Bouwman, Arne Nedergaard Kousholt, et al.. (2020). Variants of uncertain clinical significance in hereditary breast and ovarian cancer genes: best practices in functional analysis for clinical annotation. Journal of Medical Genetics. 57(8). 509–518. 32 indexed citations

Howell, Anthony, Linda Ashcroft, Lesley Fallowfield, et al.. (2017). RAZOR: A Phase II Open Randomized Trial of Screening Plus Goserelin and Raloxifene Versus Screening Alone in Premenopausal Women at Increased Risk of Breast Cancer. Cancer Epidemiology Biomarkers & Prevention. 27(1). 58–66. 4 indexed citations

Cooper, Rosalin, Hannah Markham, J M Theaker, et al.. (2017). Primary Clear Cell Microcystic Adenoma of the Sinonasal Cavity: Pathological or Fortuitous Association?. SHILAP Revista de lepidopterología. 2017. 1–5. 4 indexed citations

10.

Khan, Sofia, Rainer Fagerholm, Sajjad Rafiq, et al.. (2015). Polymorphism at 19q13.41 Predicts Breast Cancer Survival Specifically after Endocrine Therapy. Clinical Cancer Research. 21(18). 4086–4096. 11 indexed citations

11.

Rafiq, Sajjad, William Tapper, Andrew Collins, et al.. (2013). Identification of Inherited Genetic Variations Influencing Prognosis in Early-Onset Breast Cancer. Cancer Research. 73(6). 1883–1891. 28 indexed citations

12.

Rosenthal, Adam N., Lindsay Fraser, Ranjit Manchanda, et al.. (2013). RESULTS OF INTENSIVE ALGORITHM-BASED SCREENING IN THE UK FAMILIAL OVARIAN CANCER SCREENING STUDY (UK FOCSS PHASE 2). International Journal of Gynecological Cancer. 1 indexed citations

13.

Burn, John, D. Timothy Bishop, Pamela Chapman, et al.. (2011). A Randomized Placebo-Controlled Prevention Trial of Aspirin and/or Resistant Starch in Young People with Familial Adenomatous Polyposis. Cancer Prevention Research. 4(5). 655–665. 151 indexed citations

14.

Foster, Claire, D. Gareth Evans, Rosalind A. Eeles, et al.. (2004). Non-Uptake of Predictive Genetic Testing for BRCA1/2 among Relatives of Known Carriers: Attributes, Cancer Worry, and Barriers to Testing in a Multicenter Clinical Cohort. Genetic Testing. 8(1). 23–29. 56 indexed citations

15.

Hopwood, Penelope, David Wonderling, Maggie Watson, et al.. (2004). A randomised comparison of UK genetic risk counselling services for familial cancer: psychosocial outcomes. British Journal of Cancer. 91(5). 884–892. 20 indexed citations

16.

Eccles, Diana, et al.. (2003). Genetic testing for BRCA1 mutation in the UK [4] (multiple letters). The Lancet. 361(9352). 178–179. 1 indexed citations

17.

Morrison, Patrick J., C. M. Steel, N. C. Nevin, et al.. (2000). Insurance considerations for individuals with a high risk of breast cancer in Europe:Some recommendations. Research Explorer (The University of Manchester). 3 indexed citations

18.

Stratakis, Constantine A., Lawrence S. Kirschner, Susan E. Taymans, et al.. (1998). Carney Complex, Peutz-Jeghers Syndrome, Cowden Disease, and Bannayan-Zonana Syndrome Share Cutaneous and Endocrine Manifestations, But Not Genetic Loci. The Journal of Clinical Endocrinology & Metabolism. 83(8). 2972–2976. 39 indexed citations

19.

Naylor, M. Stuart, Gordon Stamp, William D. Foulkes, Diana Eccles, & Frances R. Balkwill. (1993). Tumor necrosis factor and its receptors in human ovarian cancer. Potential role in disease progression.. Journal of Clinical Investigation. 91(5). 2194–2206. 207 indexed citations

20.

Eccles, Diana, et al.. (1992). Allele loss on chromosome 11p is associated with poor survival in ovarian cancer.. PubMed. 10(2). 95–9. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact